CAMBRIDGE-1

Accelerating U.K. healthcare research

Cambridge-1 Inauguration: Supercharging Healthcare and Life Sciences Research


Having trouble viewing this video? Watch it here.

Solving the Most Pressing Medical Challenges with AI

Dedicated to advancing healthcare through digital biology, Cambridge-1’s first projects with AstraZeneca, GSK, Guy’s and St Thomas’ NHS Foundation Trust, King’s College London and Oxford Nanopore include developing a deeper understanding of dementia, cancer and other serious diseases, as well as accelerating drug discovery and genome sequencing.

Astra Zeneca
GSK
Guy's and St Thomas NHS Foundation Trust
Nanopore Technologies

Photo Gallery

Powering the World’s Fastest Supercomputers

Powering the World’s Fastest Supercomputers

Cambridge-1 brings together decades of NVIDIA’s work in accelerated computing, AI and life sciences into a single system, An NVIDIA DGX SuperPOD™ supercomputing cluster, it ranks among the worlds’ 50 fastest supercomputers and is powered by 100% renewable energy.

Unbeatable AI Performance at Scale

NVIDIA DGX SuperPOD™ delivers a turnkey AI data center solution that allows researchers to focus on insights instead of infrastructure. A full-stack data center platform with best-of-breed computing, network fabric, storage, and software tools, along with a white-glove implementation service, ensures results in weeks instead of months. Learn more about the technology powering Cambridge-1.

NVIDIA DGX SuperPOD

Sign up for the latest NVIDIA healthcare news, including updates on Cambridge-1.